$63.36
0.85% yesterday
Nasdaq, Dec 05, 10:00 pm CET
ISIN
GB00BYMT0J19
Symbol
LIVN

Livanova PLC Stock price

$63.36
+12.55 24.70% 1M
+18.51 41.27% 6M
+17.05 36.82% YTD
+12.86 25.47% 1Y
+8.26 14.99% 3Y
+5.86 10.19% 5Y
+4.53 7.70% 10Y
+35.47 127.18% 20Y
Nasdaq, Closing price Fri, Dec 05 2025
-0.54 0.85%

Key metrics

Basic
Market capitalization
$3.5b
Enterprise Value
$3.2b
Net debt
positive
Cash
$646.1m
Shares outstanding
54.6m
Valuation (TTM | estimate)
P/E
negative | 16.6
P/S
2.6 | 2.5
EV/Sales
2.4 | 2.4
EV/FCF
17.0
P/B
3.0
Financial Health
Equity Ratio
52.7%
Return on Equity
4.8%
ROCE
11.7%
ROIC
17.2%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$1.3b | $1.4b
EBITDA
$246.5m | $326.2m
EBIT
$201.6m | $280.6m
Net Income
$-217.5m | $208.9m
Free Cash Flow
$191.4m
Growth (TTM | estimate)
Revenue
8.6% | 10.1%
EBITDA
38.9% | 59.6%
EBIT
51.2% | 73.1%
Net Income
-1,018.5% | 230.4%
Free Cash Flow
76.2%
Margin (TTM | estimate)
Gross
68.5%
EBITDA
18.3% | 23.6%
EBIT
15.0%
Net
-16.1% | 15.1%
Free Cash Flow
14.2%
More
EPS
$-3.9
FCF per Share
$3.5
Short interest
4.5%
Employees
3k
Rev per Employee
$430.0k
Show more

Is Livanova PLC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Livanova PLC Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Livanova PLC forecast:

12x Buy
75%
4x Hold
25%

Analyst Opinions

16 Analysts have issued a Livanova PLC forecast:

Buy
75%
Hold
25%

Financial data from Livanova PLC

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,349 1,349
9% 9%
100%
- Direct Costs 425 425
6% 6%
32%
924 924
10% 10%
68%
- Selling and Administrative Expenses 546 546
4% 4%
40%
- Research and Development Expense 177 177
5% 5%
13%
246 246
39% 39%
18%
- Depreciation and Amortization 45 45
2% 2%
3%
EBIT (Operating Income) EBIT 202 202
51% 51%
15%
Net Profit -217 -217
1,018% 1,018%
-16%

In millions USD.

Don't miss a Thing! We will send you all news about Livanova PLC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Livanova PLC Stock News

Neutral
Business Wire
3 days ago
LONDON--(BUSINESS WIRE)---- $LIVN #epilepsy--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in Atlanta. These presentations highlight real-world evidence from the CORE-VNS study, the largest prospective, multinational observational study of VNS Th...
Neutral
Business Wire
4 days ago
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Makatsaria, Chief Executive Officer and is a member of the Executive Leadership Team. “Lucile is an accomplished health...
Neutral
Business Wire
11 days ago
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Alex Shvartsburg, Chief Financial Officer, will present a general business update during a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York City. The presentation will take place on Tues., Dec. 2, at 1:30 p.m. Eastern Standard Tim...
More Livanova PLC News

Company Profile

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom.

Head office United Kingdom
CEO Vladimir Makatsaria
Employees 2,900
Founded 1987
Website www.livanova.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today